Veracyte Ramps up Clinical Evidence Generation, Driving Gains in Prostate and Thyroid Test Business
360Dx,
NEW YORK – As evidence gathers, supporting the clinical value of its tests, Veracyte on Wednesday reported a 19 percent year…
NEW YORK – As evidence gathers, supporting the clinical value of its tests, Veracyte on Wednesday reported a 19 percent year…
NEW YORK – As evidence gathers, supporting the clinical value of its tests, Veracyte on Wednesday reported a 19 percent year-over…
Findings published in Frontiers in Endocrinology were derived from analyses of Veracyte’s comprehensive thyroid nodule database…
(Nasdaq: VCYT) today announced that data published in provide new insights into the frequency and risk of malignancy (ROM…